 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jan 11, 2022 |
| Title |
Development, Cryo-EM structure and function of potent monospecific and bispecific monoclonal antibodies that neutralize SARS-CoV-2 and variant B.1.351 |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
The COVID-19 pandemic prompted an unprecedented effort to develop effective countermeasures against SARS-CoV-2. While efficacious vaccines and certain therapeutic monoclonal antibodies are available, here, we report the development, cryo-EM structures and functional analyses of distinct potent monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 and its variant B.1.351. We established a platform for rapid identification of highly potent and specific SARS-CoV-2-neutralizing antibodies by high-throughput B cell receptor single cell sequencing of spike receptor binding domain immunized animals. We identified two highly potent and specific SARS-CoV-2 neutralizing mAb clones that have single-digit nanomolar affinity and low-picomolar avidity. We also generated a bispecific antibody of these two lead clones. The lead monospecific and bispecific antibodies showed strong neutralization ability against prototypical SARS-CoV-2 and the highly contagious South African variant B.1.351 that post a further risk of reducing the efficacy of currently available therapeutic antibodies and vaccines. The lead mAbs showed potent in vivo efficacy against authentic SARS-CoV-2 in both prophylactic and therapeutic settings. We solved five cryo-EM structures at ~3 resolution of these neutralizing antibodies in complex with the ectodomain of the prefusion spike trimer, and revealed the molecular epitopes, binding patterns and conformations between the antibodies and spike RBD, which are distinct from existing antibodies. Our recently developed antibodies expand the repertoire of the toolbox of COVID-19 countermeasures against the SARS-CoV-2 pathogen and its emerging variants.
|
| |
|
| Overall design |
10x 5' single-cell VDJ sequencing of CD138+ B cells from mice (C57BL/6 and BALBc) immunized with SARS-CoV-2 RBD. From C57BL/6 mice: 1 sample from spleen+LN, 1 sample from bone marrow. From Balbc mice: 2 samples (pooled spleen+LN+bone marrow).
|
| |
|
| Contributor(s) |
Peng L, Hu Y, Mankowski MC, Wei J, Zhao M, Ren P, Li T, Tripler T, Ye L, Chow RD, Wu C, Dong MB, Cook M, Wang G, Clark P, Nelson B, Klein D, Sutton R, Wilen CB, Xiong Y, Chen S |
| Citation(s) |
34981065, 35347138 |
| |
| Submission date |
May 18, 2021 |
| Last update date |
Apr 27, 2022 |
| Contact name |
Ryan D Chow |
| E-mail(s) |
ryan.chow@yale.edu
|
| Organization name |
Yale University
|
| Street address |
850 West Campus Drive
|
| City |
West Haven |
| State/province |
CT |
| ZIP/Postal code |
06516 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (4)
|
|
| Relations |
| BioProject |
PRJNA730844 |
| SRA |
SRP320347 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE174635_RAW.tar |
170.0 Kb |
(http)(custom) |
TAR (of CSV) |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data provided as supplementary file |
|
|
|
|
 |
Less...
More...